课题基金 / 基金详情

A phase 1 Randomized, Single-Centre, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSV¿-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects

A phase 1 Randomized, Single-Centre, Double-Blind, Placebo Controlled, Dose-Ranging Study to Evaluate the Safety and Immunogenicity of the BPSC1001 (VSV¿-ZEBOV) Ebola Virus Vaccine Candidate in Healthy Adult Subjects
一项旨在评估 BPSC1001 (VSV¿-ZEBOV) 埃博拉病毒候选疫苗在健康成人受试者中的安全性和免疫原性的 1 期随机、单中心、双盲、安慰剂对照、剂量范围研究
批准号:
317796
负责人:
Halperin Scott A
金额:
$22.29万
依托单位国家:
加拿大
项目类别:
Directed Grant
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-09-01 至 2015-06-01

项目摘要

项目成果

Halperin Scott A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canadian Immunization Research Network: directed grant extension
  • 批准号:
    450714
  • 项目类别:
    Directed Grant
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Halperin Scott A
  • 依托单位:
Trust, Acceptance and Sufficiency: Law as a Barrier to, and Enabler of, Routine and Responsive Immunization including COVID-19A
  • 批准号:
    432280
  • 项目类别:
    Directed Grant
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Halperin Scott A
  • 依托单位:
Understanding the effects of public health outbreak control policies and implementation on individuals and communities: a path to improving COVID-19 policy effectiveness
  • 批准号:
    422616
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Halperin Scott A
  • 依托单位:
Canadian Immunization Research Network: COVID-19 Vaccine Readiness
  • 批准号:
    433192
  • 项目类别:
    Directed Grant
  • 资助金额:
    $0.0万
  • 财政年份:
    2020
  • 负责人:
    Halperin Scott A
  • 依托单位:
海外基金